IL13 and neoplasm: IL-4, which shares its pathway with IL-13 [32], is known to induce Lyve-1 and other LEC markers in tumor-recruited CD11b+ cells [33], whereas deficiency in IL-10 receptor (IL-10R) caused impaired lymphatic formation due to decreased generation of M2 macrophages [34].